The JV intends to construct a plant to manufacture non-penicillin and non-cephalosporin Rx drugs and other drugs that are categorised as over-the-counter (OTC) products in Russia. It has also been contemplated to transfer 100 per cent interest in the CJSC Olifen (engaged in production of pharmaceutical substances) being held by Diod to the JV company, subject to due diligence.
429
999
255
999
1369
1670
2636
5272
4182
6000
7424
11340
19000
0
499
600
3880
0
26490
47472
450
699